The commercial seed industry consolidated into its current shape in roughly thirty months: ChemChina closed its $43 billion purchase of Syngenta in 2017, Dow and DuPont merged and spun off their agriculture business as Corteva in 2019, and Bayer completed its $63 billion acquisition of Monsanto in 2018, per U.S. antitrust filings and company disclosures from the period. Those three transactions, each cleared by the Department of Justice with mandated divestitures, are the reason four firms anchor the global seed trade today — a structure operators have bought from ever since.
Farm Press Theme publishes information, not purchasing or legal advice; this tracker sticks to deals, dates and conditions that are on the public record, and it names no party beyond what filings support.
What are the deals that built the current structure?
Four waves, all documented. The first was the agrichemical-into-seed wave of the 1990s and 2000s, when Monsanto, DuPont's Pioneer, Syngenta and others assembled the trait-and-seed businesses later consolidated. The second was the trio of mega-deals above, 2017 through 2019. The third was the remedy wave: to clear the Bayer-Monsanto deal, the DOJ required Bayer to divest its cotton, canola, soybean and vegetable seed lines plus digital farming assets to BASF, a roughly $9 billion package that made BASF a full-line seed and trait player for the first time; Dow and DuPont likewise sold seed and chemistry assets to secure approval. The fourth, quieter wave continues today through licensing agreements and regional brand ownership rather than headline mergers — which is why a familiar regional seed brand and a major-trait platform can share an owner without a new press release.
| Year closed | Transaction | Recorded condition or result |
|---|---|---|
| 2017 | ChemChina acquires Syngenta, $43 billion | Largest agrichemical deal to that date; U.S. review cleared with limited conditions |
| 2018 | Bayer acquires Monsanto, $63 billion | DOJ required divestiture of seed, trait and digital assets to BASF, about $9 billion |
| 2019 | DowDuPont agriculture business spins off as Corteva | Merger conditions included divestitures of seed and crop protection lines |
| Ongoing | Licensing, regional brand and pipeline deals | Concentration through contracts rather than mergers |
How concentrated is the market now?
By the most commonly cited tabulations — university research drawing on company annual reports — the four largest firms account for well over half of global commercial seed sales, and shares are higher in specific crops and biotech traits than in seed overall. Exact percentages vary by year, crop and counting method, which is why this tracker reports structures and deal values rather than a single market-share figure. The practical signature of the structure is easier to verify at the retail counter: fewer independent trait developers, widespread cross-licensing of the same trait packages across brand names, and refuge and trait-stewardship terms that read the same across brands because the underlying license is shared.
What have regulators done since the mega-deals?
Enforcement attention returned to seed in the 2020s. The DOJ and USDA held a joint public listening session on competition in seeds and held an open comment docket in 2022, collecting operator and grower-organization testimony on trait pricing, seed availability and contract terms; both agencies have since cited agriculture, including input markets, as a standing competition-enforcement priority. No comparably sized seed merger has been proposed since the 2017-2019 wave, so the tracker's merger rows have not moved — the open questions are licensing conduct and pricing, not new deals. Farmers wanting to weigh in or follow dockets can track the DOJ Antitrust Division's agriculture work directly.
What does consolidation mean when ordering seed?
Four documented consequences. First, trait menus converge: Enogen, Viptera-class or Xtend-class options appear across many brands because the trait owner licenses broadly, so brand choice is increasingly about germplasm and service rather than the trait itself. Second, contract terms — stewardship agreements, refuge requirements, grain-channel obligations — attach to the trait, not the brand, and they carry over wherever the trait goes. Third, seed pricing has shown more upward steadiness than machinery or land in the post-merger period, a pattern grower groups cited in the 2022 listening-session record. Fourth, the divested BASF lines and independent breeders remain the main sources of genetic diversity outside the top structures, which is where conventional and non-GMO programs typically source.
Where could the structure shift next?
Three watch points, all speculative until filed: antitrust follow-through on licensing and pricing conduct; portfolio moves by the majors' parent companies, as several carry heavy debt loads dating to the merger years; and gene-editing entrants, since edited traits outside the older transgenic stacks could yet seed new competition. Nothing announced as of April 2026 changes the table above. The structure operators buy from today is the one the 2017-2019 deals built, conditioned by the DOJ's divestiture remedies.
Frequently asked questions
Which companies control most of the seed market?
Bayer, Corteva, Syngenta Group and BASF anchor the global industry following the 2017-2019 deals, with university tabulations placing the top firms' combined share at well over half of commercial seed sales.
Did regulators block any of the big seed mergers?
None was blocked outright. The DOJ cleared Bayer-Monsanto and Dow-DuPont only with major divestitures, including Bayer's roughly $9 billion seed and digital asset sale to BASF.
Why do different seed brands offer the same traits?
Cross-licensing. The trait owner licenses packages to multiple brands, so the trait, and its contract terms, appear under many names while germplasm differs.
Has concentration affected seed prices?
Grower organizations testified to steady input-price pressure in the 2022 DOJ-USDA listening-session record; this site reports the testimony without forecasting prices.
For more context, read Agtech funding in 2026 holds steady, unevenly distributed.
For more context, read agriculture tariffs 2026.
For more context, read USDA's August 2025 WASDE sized a big corn crop.